Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Antimicrobial peptides: An emerging category of therapeutic agents
Promore Pharma AB, Sweden; University of Gothenburg, Sweden.
RISE., SP – Sveriges Tekniska Forskningsinstitut, SP Kemi Material och Ytor, Medicinteknik.ORCID-id: 0000-0002-4270-8475
RISE., SP – Sveriges Tekniska Forskningsinstitut, SP Kemi Material och Ytor, Life Science.
RISE., SP – Sveriges Tekniska Forskningsinstitut, SP Kemi Material och Ytor, Medicinteknik. University of Gothenburg, Sweden.ORCID-id: 0000-0002-3034-6745
2016 (engelsk)Inngår i: Frontiers in Cellular and Infection Microbiology, E-ISSN 2235-2988, Vol. 6, nr DEC, artikkel-id 194Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance development to conventional antibiotics all over the world, efforts to bring AMPs into clinical use are accelerating. Several AMPs are currently being evaluated in clinical trials as novel anti-infectives, but also as new pharmacological agents to modulate the immune response, promote wound healing, and prevent post-surgical adhesions. In this review, we provide an overview of the biological role, classification, and mode of action of AMPs, discuss the opportunities and challenges to develop these peptides for clinical applications, and review the innovative formulation strategies for application of AMPs.

sted, utgiver, år, opplag, sider
Frontiers Research Foundation , 2016. Vol. 6, nr DEC, artikkel-id 194
Emneord [en]
AMP, antimicrobial peptide, anti-infectives, antibiotic resistance, therapeutic agents
HSV kategori
Identifikatorer
URN: urn:nbn:se:ri:diva-27767DOI: 10.3389/fcimb.2016.00194Scopus ID: 2-s2.0-85009823798OAI: oai:DiVA.org:ri-27767DiVA, id: diva2:1062568
Merknad

Published 27 December

Tilgjengelig fra: 2017-01-06 Laget: 2017-01-06 Sist oppdatert: 2023-05-22bibliografisk kontrollert

Open Access i DiVA

fulltext(2137 kB)210 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 2137 kBChecksum SHA-512
e558067a99fb9dc7b0a2fce08a7e8baabbd26be8915d23553aa934adc8672174e3b62e3daebfe9a84fc73677ca66125ee231b93da31baa8597aaa5758030ec56
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstScopusOpen access article at publishers website

Person

Håkansson, JoakimBjörn, Camilla

Søk i DiVA

Av forfatter/redaktør
Håkansson, JoakimBjörn, Camilla
Av organisasjonen
I samme tidsskrift
Frontiers in Cellular and Infection Microbiology

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 223 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 283 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
v. 2.43.0